Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	COMMON STOCK	ADDITIONAL PAID-IN CAPITAL	ACCUMULATED DEFICIT	At The Market Offering	At The Market Offering COMMON STOCK	At The Market Offering ADDITIONAL PAID-IN CAPITAL
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ending balance (in shares)		23,192,866
Ending balance	$ 261,721	$ 2	$ 326,730	$ (65,011)
Beginning balance (in shares) at Dec. 31, 2020		23,192,866
Beginning balance at Dec. 31, 2020	261,721	$ 2	326,730	(65,011)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of underwriting discounts, commissions and offering costs (in shares)						520,000
Issuance of common stock, net of underwriting discounts, commissions and offering costs					$ 28,096		$ 28,096
Exercise of common stock options (in shares)		261,968
Exercise of common stock options	379		379
Stock-based compensation	11,722		11,722
Net loss	(58,744)			(58,744)
Ending balance (in shares)		23,974,834
Ending balance	243,174	$ 2	366,927	(123,755)
Beginning balance (in shares) at Dec. 31, 2021		23,974,834
Beginning balance at Dec. 31, 2021	$ 243,174	$ 2	366,927	(123,755)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of underwriting discounts, commissions and offering costs (in shares)						3,410,384
Issuance of common stock, net of underwriting discounts, commissions and offering costs					$ 119,428		$ 119,428
Exercise of common stock options (in shares)	158,235	158,235
Exercise of common stock options	$ 818		818
Stock-based compensation	18,682		18,682
Net loss	(104,679)			(104,679)
Ending balance (in shares)		27,543,453
Ending balance	$ 277,423	$ 2	$ 505,855	$ (228,434)